HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Arcadia Biosciences Bites Into Cannabinoid Market, Buys Firms From Rapper Jay-Z’s Company

Executive Summary

Food ingredient firm Arcadia Biosciences acquired CBD supplements and coconut waters from rapper Jay-Z’s cannabis market holding company and is thinking about opportunities to expand into additional cannabinoid segments, including beverages.

You may also be interested in...



DSM Remodels Nutrition Business With Fundamental Piece – Cannabinoid Ingredients

Royal DSM and Colorado’s Mile High Labs partner to provide companies in supplement, food and beverage sectors with ingredients to develop formulations with CBD and other cannabinoids. They initially are targeting the US and look to enter Canada, South America, Europe and Australia.

US FDA Continues Cannabinoid Analysis Required In FY2021 Budget

FDA is testing cannabidiol and other cannabinoids for whether labeled amounts match what’s in a product, says CFSAN Deputy Director Doug Stearn. The work is supported with $5m provided in the agency’s FY21 appropriation.

US Senate Appetite For Lawful Use Of Cannabinoids Includes Food On Top Of Supplements

Senate bill introduced on 19 May, unlike a House bill introduced in February, would direct FDA to allow using hemp-derived cannabinoids in food products as well as supplements. However, neither bill includes language on setting a safe daily level that some industry stakeholders argue is needed.

Topics

UsernamePublicRestriction

Register

RS151357

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel